Dr. John M. Garvey is a partner in the Boston office. John works with emerging technology and life-science companies, advising clients on the creation of proprietary brands and technology assets, and monetization of these assets in connection with client business objectives.
John's clients include academic medical centers, startup and private organizations as well as publicly traded companies, and encompass such diverse markets as: cancer therapeutics and diagnostics, ocular disease and ocular devices, immunology, infection and vaccine technologies, adult stem cells, tissue and organ grafts, medical lasers, transgenic technologies, diabetes, targeted drug delivery, computationally assisted drug design, bio-weapons detection and neutralization, blood and blood products, orthopedic medicine, cosmetic medicine and medical devices. In addition, John represents high-tech, software, functional foods/nutraceuticals and nanotech companies.
John's legal practice encompasses: intellectual property prosecution and counseling, IP opinions, patent interferences and re-examinations, technology transfer and cross-border licensing, research collaborations, clinical trials and development of regulated products, representing investors in private equity/venture capital transactions, corporate finance and SEC compliance, trademarks/branding and mergers & acquisitions.